Device
Ureteral stent
Ureteral stent is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph early_phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_2
1
17%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
40.0%
2 of 5 finished
Non-Completion Rate
60.0%
3 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(2)
Terminated(3)
Detailed Status
Completed2
Withdrawn2
Active, not recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)
Trials by Status
active_not_recruiting117%
completed233%
withdrawn233%
terminated117%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruitingnot_applicable
Optimal Stent Duration After Ureteroscopy
NCT06045962
withdrawnearly_phase_1
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
NCT05640115
completednot_applicable
Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney
NCT03498794
withdrawn
The Impact of Ureteral Stents on Peristalsis
NCT01739738
terminated
Ureteral Stent Length and Patient Symptoms
NCT00288457
Clinical Trials (6)
Showing 6 of 6 trials
NCT06045962Not Applicable
Optimal Stent Duration After Ureteroscopy
NCT05640115Early Phase 1
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
NCT03498794Not Applicable
Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney
NCT01739738
The Impact of Ureteral Stents on Peristalsis
NCT00288457
Ureteral Stent Length and Patient Symptoms
NCT00250406Phase 2
Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6